Prevalence of hepatitis B in the focus of HIV infection

Highly sensitive up-to-date research methods (enzyme immunoassay) for HbsAg and antibodies against HBsAg and HBcAg were employed to examine 565 adults and children living in the Kalmuck++ ASSR (Elista and adjacent regions), where in 1988-1989 cases of HIV-infection were recorded. Markers of HBV-infection were detected with a high enough frequency in the control group of children (15.2%). The prevalence of the infection in the adult population was at an intermediate level (38.9%). The high infectivity with HBV-infection was recorded among children who had been hospitalized before (for different diseases including chronic ones), among women who had undergone laboratory studies because of the diagnosis of HIV-infection in their children; among adult patients suffering from tuberculosis of morons from a closed boarding school. The highest frequency of HBV-infection marker demonstration was found in HIV-infected children (70%). The data obtained point to the necessity of vaccination against viral hepatitis B in risk groups (children and adults) and in the newborn as well as of raising the efficacy of preventing measures against infections transmitted via blood.

Medienart:

Artikel

Erscheinungsjahr:

1992

Erschienen:

1992

Enthalten in:

Zur Gesamtaufnahme - year:1992

Enthalten in:

Pediatriia - (1992), 1 vom: 28., Seite 56-60

Sprache:

Russisch

Weiterer Titel:

Rasprostranennost' virusnogo gepatita B v ochage infektsii, vyzvannoĭ virusom immunodefitsita cheloveka

Beteiligte Personen:

Uchaĭkin, V F [VerfasserIn]
Kaganov, B S [VerfasserIn]
Moleva, T P [VerfasserIn]
Sokolova, N V [VerfasserIn]
Sharaeva, N B [VerfasserIn]
Konev, V A [VerfasserIn]
Stepanov, A N [VerfasserIn]

Themen:

Biomarkers
Comparative Study
English Abstract
Hepatitis B Core Antigens
Hepatitis B Surface Antigens
Journal Article

Anmerkungen:

Date Completed 27.07.1992

Date Revised 23.05.2016

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM015169227